Advisory Board

Professor of Medicine at the Katholieke Universiteit and Endocrinologist at the University Hospital Gasthuisberg Leuven, Belgium.

Chantal Mathieu is a physician-scientist who has contributed to the field of diabetes and endocrinology through basic and clinical research. Her basic research work focuses on pathogenesis and prevention of type 1 diabetes, including the immune effects of vitamin D. Prof. Mathieu’s clinical work involves studies of new products and treatment paradigms in diabetes, screening for type 1 diabetes, arresting type 1 diabetes, diabetes and pregnancy, new insulins and other therapies in diabetes, novel technologies and adjunct therapies in type 1 diabetes have made her a speaker in international fora. Prof. Mathieu coordinates the European clinical trial network for interventions in type 1 diabetes ‘INNODIA’ and the European project ‘EDENT1FI’ on screening for type 1 diabetes. Prof. Mathieu is president of EASD and vice-president of the European Diabetes Forum.